Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-237-7 | CAS number: 1314-60-9
Carcinogenicity
Administrative data
Description of key information
According to the data requirements as laid out in Column 2, Section 8.9.1, Annex X of regulation (EC) 1907/2006 a carcinogenicity study may be considered in case (a) the substance has a widespread dispersive use or there is evidence of frequent or long-term human exposure, and (b) the substance is classified as mutagen category 3 or there is evidence from the repeated dose study(ies) that the substance is able to induce hyperplasia and/or preneoplastic lesions. Since none of the afore mentioned criteria are fulfilled for pentavalent antimony compounds such as sodium hexahydroxoantimonate, sodium andimonate and antimony pentoxide, and a 90-day repeated dose toxicity study via oral application with sodium hexahydroxoantimonate showed no evidence of induction of hyperplasia and/or preneoplastic lesions up to the limit dose of 1000 mg/kg/d (Hansen, 2013), testing for carcinogenicity for this substance is waived.
Key value for chemical safety assessment
Justification for classification or non-classification
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
